The Board of the Lee's Pharmaceutical Holdings Limited announced that, Samir C. Patel, MD has been appointed as the Chief Strategy Officer of the Company's indirect non-wholly owned subsidiary, China Ophthalmology Focus Limited with effect from 9 April 2020. Prior to his appointment in this newly created position, Dr. Patel has extensive experiencewith a number of start-up and well-established pharmaceutical companies. He was the Co- Founder, President and Chief Executive Officer of Ophthotech Corporation.